BlackRock Inc. (0QZZ)
London Exchange · UK · prices in USD · close of 20 Oct 2026
Key indicators
| Last close | USD 1,130.07 |
|---|---|
| 52-week range | 905.06 – 1,194.36 |
| Return, 1 month / 3 months | +4.4% / +9.2% |
| Return, 1 year / 3 years | −0.5% / +88.0% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -22.1% |
| Average daily value traded | 0.78M USD |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BlackRock is an investment management company based in New York. It manages money on behalf of institutions, financial advisers and individual investors, offering mutual funds, exchange-traded funds through its iShares brand, and separate accounts. Its clients include pension funds, governments, foundations and corporations, and it also provides advisory and risk management services. The firm operates across global markets and offers both index-tracking and actively managed strategies spanning equities, bonds and other asset classes.
On this site BlackRock Inc. appears as a stock on the London Exchange (UK), code 0QZZ, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BlackRock Inc. (0QZZ) trades on the London Exchange in UK. It last closed at USD 1,130.07 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 947 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.5% and over the last three months it rose 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.3% | ||
| From 52-week high | -3.7% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.2% | ||
| 6-month return | 7.5% | ||
| 12-month return, skipping the last month | -4.8% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.1% | ||
| Liquidity | 50 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.78M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 72 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.8% |
|---|---|
| 1 month | +4.4% |
| 3 months | +9.2% |
| 6 months | +7.5% |
| 1 year | −0.5% |
| 3 years | +88.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,104.44 / 1,053.30 |
|---|---|
| Golden / death cross (60 days) | Golden, 46 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 44.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Sep 2026 | USD 5.7300 |
| 4 Jun 2026 | USD 5.7300 |
| 5 Mar 2026 | USD 5.7300 |
| 4 Dec 2025 | USD 5.2100 |
| 4 Sep 2025 | USD 5.2100 |
| 4 Jun 2025 | USD 5.2100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.